Innovotech Labs Corporation

Innovotech Labs Corporation is a contract research organization and a wholly owned subsidiary of the diversified Canadian technology company Innovotech Inc. The organization provides specialized laboratory services, including proprietary devices for antimicrobial testing designed for applications such as medical devices like catheters, implants, and wound dressings. Beyond testing, the company is involved in commercializing antimicrobial silver solutions, including the development of silver compounds like InnovoSIL-1. In January 2026, the company amalgamated with Keystone Labs Inc. to form a single entity, continuing to operate as Innovotech Labs Corporation under the broader Innovotech Inc. corporate structure, which is listed on the TSX Venture Exchange.

These services and products are essential for medical device manufacturers and industrial clients needing to navigate evolving international regulatory standards regarding biofilm formation, proliferation, and microbial translocation. By providing specialized technical expertise and developing innovative antimicrobial solutions, the company assists clients in reducing infections and improving health outcomes. Their laboratory operations are accredited to ISO/IEC 17025:2017 standards, ensuring technical competence for their defined scope of services. The company also engages in research and development supported by government initiatives, such as the NRC IRAP, to expand its technical capabilities and address complex challenges in antimicrobial product development.